Immune Checkpoint Inhibitor
Statins may enhance effectiveness of immune checkpoint inhibitors
Concomitant use of statins improved survival among people with cancer treated with immune checkpoint inhibitors, according to results of a meta-analysis.
Immune checkpoint inhibitors with transplant improve survival in relapsed Hodgkin lymphoma
Pre-transplant immune checkpoint inhibitors extended survival for patients with relapsed classic Hodgkin lymphoma compared with chemotherapy, according to results of a retrospective study.
Immune checkpoint inhibitor therapy doubles psoriasis risk
Patients with cancer who received immune checkpoint inhibitors exhibited increased risk for psoriasis compared with those treated with chemotherapy or targeted therapy.
Neoadjuvant immune checkpoint inhibitor therapy improves outcomes in early breast cancer
The addition of immune checkpoint inhibitor therapy to neoadjuvant chemotherapy improved pathologic complete response and EFS for certain patients with early-stage breast cancer, according to a systematic review and meta-analysis.
Typical care resolves respiratory symptoms that come with immune checkpoint inhibitors
BOSTON — Patients with eosinophilic reactive airway disease after immune checkpoint inhibitor therapy saw improved symptoms with typical treatment for reactive airway disease, according to a study presented at the CHEST Annual Meeting.
’Much work remains’ to ensure adequate diversity in trials of immune checkpoint inhibitors
Although progress has been made, lack of diversity continues to be problematic in trials of immune checkpoint inhibitors, according to study results.
Findings reveal ‘crucial’ need to manage immune checkpoint inhibitor-induced myocarditis
Patients with cancer who received immune checkpoint inhibitors rarely developed cardiovascular adverse events, according to results of a systematic review and meta-analysis.
Obesity associated with longer survival in immunotherapy-treated head, neck cancer
An analysis of patients with head and neck squamous cell carcinoma who received immune checkpoint inhibitors showed those with obesity survived longer than those with normal BMI.